FOSAPREPITANT DIMEGLUMINE
- Product NDC
- 82238-018
- 11-digit product format
- 822380018
- Labeler code
- 82238
- Product ID
- 82238-018_01fd547a-5dd1-48b7-8450-8151170b21b7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- FOSAPREPITANT DIMEGLUMINE
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- EUGIA Pharma Specialities Limited
- Application
- ANDA210625
- Marketing category
- ANDA
- Marketing start
- 2021-01-12
- Marketing end
- 0000-00-00
- Substance
- FOSAPREPITANT DIMEGLUMINE
- Active strength
- 150 mg/5mL
- Pharmacologic classes
- Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 82238-018-01 | 82238001801 | 1 VIAL, SINGLE-DOSE in 1 CARTON (82238-018-01) > 5 mL in 1 VIAL, SINGLE-DOSE | 2021-01-12 | 0000-00-00 | No | No | Current |